| Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man DR Matthews, JP Hosker, AS Rudenski, BA Naylor, DF Treacher, ... diabetologia 28, 412-419, 1985 | 38470 | 1985 |
| Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33) UK Prospective Diabetes Study (UKPDS) Group The lancet 352 (9131), 837-853, 1998 | 24907 | 1998 |
| Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study IM Stratton, AI Adler, HAW Neil, DR Matthews, SE Manley, CA Cull, ... bmj 321 (7258), 405-412, 2000 | 12864 | 2000 |
| 10-year follow-up of intensive glucose control in type 2 diabetes RR Holman, SK Paul, MA Bethel, DR Matthews, HAW Neil New England journal of medicine 359 (15), 1577-1589, 2008 | 10394 | 2008 |
| Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34) UK Prospective Diabetes Study (UKPDS) Group The Lancet 352 (9131), 854-865, 1998 | 9419 | 1998 |
| Canagliflozin and cardiovascular and renal events in type 2 diabetes B Neal, V Perkovic, KW Mahaffey, D De Zeeuw, G Fulcher, N Erondu, ... New England Journal of Medicine 377 (7), 644-657, 2017 | 8383 | 2017 |
| Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38 UK Prospective Diabetes Study Group Bmj 317 (7160), 703-713, 1998 | 7987 | 1998 |
| Management of hyperglycemia in type 2 diabetes: a patient-centered approach: position statement of the American Diabetes Association (ADA) and the European Association for the … SE Inzucchi, RM Bergenstal, JB Buse, M Diamant, E Ferrannini, M Nauck, ... Diabetes Spectrum 25 (3), 154-171, 2012 | 7691* | 2012 |
| Use and abuse of HOMA modeling TM Wallace, JC Levy, DR Matthews Diabetes care 27 (6), 1487-1495, 2004 | 6196 | 2004 |
| Management of hyperglycemia in type 2 diabetes, 2015: a patient-centered approach: update to a position statement of the American Diabetes Association and the European … SE Inzucchi, RM Bergenstal, JB Buse, M Diamant, E Ferrannini, M Nauck, ... Diabetes care 38 (1), 140-149, 2015 | 3784 | 2015 |
| Publication bias in clinical research PJ Easterbrook, R Gopalan, JA Berlin, DR Matthews The Lancet 337 (8746), 867-872, 1991 | 3674 | 1991 |
| Association of systolic blood pressure with macrovascular and microvascular complications of type 2 diabetes (UKPDS 36): prospective observational study AI Adler, IM Stratton, HAW Neil, JS Yudkin, DR Matthews, CA Cull, ... Bmj 321 (7258), 412-419, 2000 | 3164 | 2000 |
| Risk factors for coronary artery disease in non-insulin dependent diabetes mellitus: United Kingdom Prospective Diabetes Study (UKPDS: 23) RC Turner, H Millns, HAW Neil, IM Stratton, SE Manley, DR Matthews, ... Bmj 316 (7134), 823-828, 1998 | 2986 | 1998 |
| Correct homeostasis model assessment (HOMA) evaluation uses the computer program JC Levy, DR Matthews, MP Hermans Diabetes care 21 (12), 2191, 1998 | 2397 | 1998 |
| Effect of rosiglitazone on the frequency of diabetes in patients with impaired glucose tolerance or impaired fasting glucose: a randomised controlled trial DREAM (Diabetes REduction Assessment with ramipril and rosiglitazone ... The Lancet 368 (9541), 1096-1105, 2006 | 2276 | 2006 |
| Efficacy of atenolol and captopril in reducing risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 39 UK Prospective Diabetes Study Group Bmj 317 (7160), 713-720, 1998 | 2244 | 1998 |
| UK Prospective Diabetes Study 16: overview of 6 years' therapy of type II diabetes: a progressive disease UK Prospective Diabetes Study Group Diabetes 44 (11), 1249-1258, 1995 | 1874 | 1995 |
| Efficacy and safety comparison of liraglutide, glimepiride, and placebo, all in combination with metformin, in type 2 diabetes: the LEAD (liraglutide effect and action in … M Nauck, A Frid, K Hermansen, NS Shah, T Tankova, IH Mitha, ... Diabetes care 32 (1), 84-90, 2009 | 1576 | 2009 |
| UKPDS 50: risk factors for incidence and progression of retinopathy in Type II diabetes over 6 years from diagnosis IM Stratton, EM Kohner, SJ Aldington, RC Turner, RR Holman, SE Manley, ... Diabetologia 44, 156-163, 2001 | 1384 | 2001 |
| Psychosocial problems and barriers to improved diabetes management: results of the Cross‐National Diabetes Attitudes, Wishes and Needs (DAWN) Study M Peyrot, RR Rubin, T Lauritzen, FJ Snoek, DR Matthews, SE Skovlund Diabetic medicine 22 (10), 1379-1385, 2005 | 1261 | 2005 |